AARD·002942100·US·equity·Healthcare - Biotechnology-13D/G
AARD (AARDVARK THERAPEUTICS INC) is held by 48 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($4.7M), BlackRock, Inc. ($3M), GEODE CAPITAL MANAGEMENT, LLC ($1.2M). Net institutional sentiment: Mixed.
See how AARD's score breaks down across 4 SEC sources
Showing 1-20 of 57
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer